Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Martin Roatsch"'
Autor:
Finn K. Hansen, Alexandra Hamacher, Jens Meiler, Jan J. Bandolik, Martin Roatsch, Clara T. Schoeder, Andrea Schöler, Laura Sinatra, Sanil Bhatia, Matthias U. Kassack, Melf Sönnichsen, Arndt Borkhardt
Publikováno v:
Sinatra, L, Bandolik, J J, Roatsch, M, Soennichsen, M, Schoeder, C T, Hamacher, A, Schoeler, A, Borkhardt, A, Meiler, J, Bhatia, S, Kassack, M U & Hansen, F K 2020, ' Hydroxamic Acids Immobilized on Resins (HAIRs) : Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs) ', Angewandte Chemie International Edition, vol. 59, no. 50, pp. 22494-22499 . https://doi.org/10.1002/anie.202006725
Angewandte Chemie (International Ed. in English)
Angewandte Chemie (International Ed. in English)
Inhibition of more than one cancer‐related pathway by multi‐target agents is an emerging approach in modern anticancer drug discovery. Here, based on the well‐established synergy between histone deacetylase inhibitors (HDACi) and alkylating age
Autor:
Finn K. Hansen, Jens Meiler, Martin Roatsch, Andrea Schöler, Laura Sinatra, Melf Sönnichsen, Arndt Borkhardt, Alexandra Hamacher, Clara T. Schoeder, Jan J. Bandolik, Sanil Bhatia, Matthias U. Kassack
Publikováno v:
Angewandte Chemie. 132:22681-22687
Autor:
Martin Roatsch, Andreas Link, Oxana Krylova, Udo Heinemann, Nicole Rüger, Manfred Jung, Piotr H. Małecki, Manfred S. Weiss
Publikováno v:
Małecki, P H, Rüger, N, Roatsch, M, Krylova, O, Link, A, Jung, M, Heinemann, U & Weiss, M S 2019, ' Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases ', ChemMedChem, vol. 14, no. 21, pp. 1828-1839 . https://doi.org/10.1002/cmdc.201900441
Chemmedchem
Chemmedchem
Human histone demethylases are known to play an important role in the development of several tumor types. Consequently, they have emerged as important medical targets for the treatment of human cancer. Herein, structural studies on tetrazolylhydrazid
Publikováno v:
Epigenetic Drug Discovery
Histone deacetylases (HDACs) remove acetyl groups from histone proteins and are implicated in gene regulation. They have been recognized as drug targets for treatment of cancer and other human diseases and several inhibitors are already clinically us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6852e810ed762b7a4ac62c3b125ecf5
https://doi.org/10.26434/chemrxiv.12416303
https://doi.org/10.26434/chemrxiv.12416303
Autor:
Isabelle Moneke, Roland Schüle, Erik Schleicher, Akane Kawamura, Silke Lassmann, Hanna Tarhonskaya, Dina Robaa, Kuo-Feng Hsu, Martine I. Abboud, Rebecca L. Hancock, Wolfgang Sippl, Henriette Franz, Kerstin Lippl, Christopher J. Schofield, Nicolas P F Barthes, Theresa D. Ahrens, Manfred Jung, Sarah E. Wilkins, Sandra Wenzler, Martin Roatsch, Tzu Lan Yeh, Inga Hoffmann, Sven Diederichs, Kerstin Serrer
Publikováno v:
ACS chemical biology. 14(8)
Fe(II)- and 2-oxoglutarate (2OG)-dependent JumonjiC domain-containing histone demethylases (JmjC KDMs) are epigenetic eraser enzymes involved in the regulation of gene expression and are emerging drug targets in oncology. We screened a set of clinica
Autor:
Manfred Jung, Martin Roatsch, Inga Hoffmann, Martine I. Abboud, Rebecca L. Hancock, Hanna Tarhonskaya, Kuo-Feng Hsu, Sarah E. Wilkins, Tzu-lan Yeh, Kerstin Lippl, Kerstin Serrer, Isabelle Moneke, Theresa D. Ahrens, Dina Robaa, Sandra Wenzler, Henriette Franz, Wolfgang Sippl, Silke Lassmann, Sven Diederichs, Erik Schleicher, Christopher J. Schofield, Akane Kawamura, Roland Schüle
Fe(II)- and 2-oxoglutarate (2OG)-dependent JumonjiC domain-containing histone demethylases (JmjC KDMs) are epigenetic eraser enzymes involved in the regulation of gene expression and are emerging drug targets in oncology. We screened a set of clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e472f20dd442521931b9fcd32e8099d
https://doi.org/10.26434/chemrxiv.7699853
https://doi.org/10.26434/chemrxiv.7699853
Autor:
Manfred Jung, Martin Roatsch, Inga Hoffmann, Martine I. Abboud, Rebecca L. Hancock, Hanna Tarhonskaya, Kuo-Feng Hsu, Tzu-lan Yeh, Kerstin Lippl, Kerstin Serrer, Isabelle Moneke, Theresa D. Ahrens, Dina Robaa, Sandra Wenzler, Henriette Franz, Wolfgang Sippl, Silke Lassmann, Sven Diederichs, Erik Schleicher, Christopher J. Schofield, Akane Kawamura, Roland Schüle
Fe(II)- and 2-oxoglutarate (2OG)-dependent JumonjiC domain-containing histone demethylases (JmjC KDMs) are epigenetic eraser enzymes involved in the regulation of gene expression and are emerging drug targets in oncology. We screened a set of clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00aa6548d5216e917e4102bd35fce6f5
https://doi.org/10.26434/chemrxiv.7699853.v1
https://doi.org/10.26434/chemrxiv.7699853.v1
Autor:
Martin Roatsch, Nicole Rüger, Manfred Jung, Roland Schüle, Henriette Franz, Thomas Emmrich, Andreas Link
Publikováno v:
ChemMedChem. 10:1875-1883
The JumonjiC-domain-containing histone demethylase 2A (JMJD2A, KDM4A) is a key player in the epigenetic regulation of gene expression. Previous publications have shown that both elevated and lowered enzyme levels are associated with certain types of
Autor:
Oxana Krylova, Manfred Jung, Nicole Rüger, Andreas Link, Martin Roatsch, Udo Heinemann, Manfred S. Weiss, Piotr H. Małecki
Publikováno v:
ChemMedChem. 14:1803-1803